Searched for
ATORVASTATIN CALCIUM TABLETS
Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...- Over 140,000 bottles of cholesterol-lowering drug recalled: Safety concerns with Atorvastatin calcium tabletsA major recall is underway for over 140,000 bottles of Atorvastatin Calcium Tablets. This popular cholesterol medication, the generic form ...
- Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in USAs per the US Food and Drug Administration's latest Enforcement report, the Hyderabad-based drug major is voluntarily recalling the affecte...
- Sun Pharma, Dr Reddy's, Aurobindo recall products in the US marketAs per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Sun Pharma is recalling Cequa ophthalmic solution, whi...
- Stocks in focus: IDBI Bank, Tata Steel, RITES & Fine Organic among top stocks to trackHere is a list of top stocks that are likely to be in focus in today's trading session -
- Dr Reddy's recalls 2.36 lakh bottles of cholesterol lowering tablets from USA class III recall is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health c...
- Top stocks in focus on 09 February 2018Here is a list of top stocks that are likely to take focus in today's trading session.
- Dr Reddy's recalls 80,000+ bottles of Atorvastatin from USThe product is being recalled through three separate letters to the drug regulator. Dr Reddy's officials were not immediately available for...
- Dr Reddy's recalls over 55K bottles of hypertension drug in USDr Reddy's Laboratories is recalling over 55,000 bottles of Amlodipine besylate and Atorvastatin calcium tablets.
- Dr Reddy's Laboratories recalls anti-seizure, hypertension drugs from US marketThe firm has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests.
- Dr Reddy's launches generic cholesterol-lowering drug in USDr Reddy's Laboratories shares were trading at Rs 2,594 apiece on the BSE in afternoon trade, down 1.60 per cent from its previous close.
- Ranbaxy shares settle 1.51 per cent down; market capitalisation erodes by Rs 43 croreShares of Ranbaxy Laboratories today settled for the day with losses of 1.51 %, pursuant to which the market capitalisation eroded by Rs 43...
- Ranbaxy Laboratories recalls over 64,000 bottles Lipitor; stock slips over 3%The FDA declared a Class II recall, which signifies a remote chance of severe adverse consequences or death due to the product flaw.
- Drugmakers Ranbaxy, Teva reach pact to compete in US marketThe agreement kept the two companies from challenging each other’s right to sell certain drugs exclusively in the US.
- Ranbaxy surprises street with Q4 loss of Rs 492 croreThe Gurgaon-based firm has provisioned Rs 186 crore to deal with the costs arising out of the product recall.
- Ranbaxy restarts generic Lipitor production for US marketPharma major Ranbaxy Laboratories restarts production of generic cholesterol lowering drug Atorvastatin as it looks to resume supplies to U...
- Dr Reddy's launches Atorvastatin calcium tablets in USDr Reddy's said that it has launched Atorvastatin calcium tablets, a bioequivalent generic version of Lipitor tablets in the US.
- Ranbaxy begins Atorvastation exports to USRanbaxy Laboratories has commenced exports of Atorvastation Calcium tablets to the US market from its Mohali SEZ manufacturing facility.
- Ranbaxy gets USFDA nod to sell LipitorThe approval marks an end to months of uncertainty surrounding approval of the drug which could earn Ranbaxy over $500 mn. Stock quote
- Pfizer drags DRL to court over Lipitor copy launchPfizer has taken Dr Reddy’s Laboratories to court to delay the launch of the Indian drug maker’s low-cost version of atorvastatin in the US...
Load More
